69 related articles for article (PubMed ID: 38674283)
41. ABCB1, ABCC2, SCN1A, SCN2A, GABRA1 gene polymorphisms and drug resistant epilepsy in the Chinese Han population.
Zhou L; Cao Y; Long H; Long L; Xu L; Liu Z; Zhang Y; Xiao B
Pharmazie; 2015 Jun; 70(6):416-20. PubMed ID: 26189305
[TBL] [Abstract][Full Text] [Related]
42. Incidence, prevalence and aetiology of seizures and epilepsy in children.
Camfield P; Camfield C
Epileptic Disord; 2015 Jun; 17(2):117-23. PubMed ID: 25895502
[TBL] [Abstract][Full Text] [Related]
43. SCN1A variations and response to multiple antiepileptic drugs.
Yip TS; O'Doherty C; Tan NC; Dibbens LM; Suppiah V
Pharmacogenomics J; 2014 Aug; 14(4):385-9. PubMed ID: 24342961
[TBL] [Abstract][Full Text] [Related]
44. Effects of SCN1A and GABA receptor genetic polymorphisms on carbamazepine tolerability and efficacy in Chinese patients with partial seizures: 2-year longitudinal clinical follow-up.
Zhou BT; Zhou QH; Yin JY; Li GL; Qu J; Xu XJ; Liu D; Zhou HH; Liu ZQ
CNS Neurosci Ther; 2012 Jul; 18(7):566-72. PubMed ID: 22591328
[TBL] [Abstract][Full Text] [Related]
45. The Role of ATP-Binding Cassette Transporters in Neuro-Inflammation: Relevance for Bioactive Lipids.
Kooij G; van Horssen J; Bandaru VV; Haughey NJ; de Vries HE
Front Pharmacol; 2012; 3():74. PubMed ID: 22557971
[TBL] [Abstract][Full Text] [Related]
46. Comprehensive analysis of the association of SCN1A gene polymorphisms with the retention rate of carbamazepine following monotherapy for new-onset focal seizures in the Chinese Han population.
Zhou BT; Zhou QH; Yin JY; Li GL; Xu XJ; Qu J; Liu D; Zhou HH; Liu ZQ
Clin Exp Pharmacol Physiol; 2012 Apr; 39(4):379-84. PubMed ID: 22292851
[TBL] [Abstract][Full Text] [Related]
47. Association of alpha subunit of GABAA receptor subtype gene polymorphisms with epilepsy susceptibility and drug resistance in north Indian population.
Kumari R; Lakhan R; Kalita J; Misra UK; Mittal B
Seizure; 2010 May; 19(4):237-41. PubMed ID: 20356767
[TBL] [Abstract][Full Text] [Related]
48. Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders.
Mantegazza M; Curia G; Biagini G; Ragsdale DS; Avoli M
Lancet Neurol; 2010 Apr; 9(4):413-24. PubMed ID: 20298965
[TBL] [Abstract][Full Text] [Related]
49. Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy.
Sánchez MB; Herranz JL; Leno C; Arteaga R; Oterino A; Valdizán EM; Nicolás JM; Adín J; Armijo JA
Seizure; 2010 Mar; 19(2):93-101. PubMed ID: 20064729
[TBL] [Abstract][Full Text] [Related]
50. Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression.
Kwan P; Poon WS; Ng HK; Kang DE; Wong V; Ng PW; Lui CH; Sin NC; Wong KS; Baum L
Pharmacogenet Genomics; 2008 Nov; 18(11):989-98. PubMed ID: 18784617
[TBL] [Abstract][Full Text] [Related]
51. Association between SCN1A polymorphism and carbamazepine-resistant epilepsy.
Abe T; Seo T; Ishitsu T; Nakagawa T; Hori M; Nakagawa K
Br J Clin Pharmacol; 2008 Aug; 66(2):304-7. PubMed ID: 18489610
[TBL] [Abstract][Full Text] [Related]
52. Nova2 interacts with a cis-acting polymorphism to influence the proportions of drug-responsive splice variants of SCN1A.
Heinzen EL; Yoon W; Tate SK; Sen A; Wood NW; Sisodiya SM; Goldstein DB
Am J Hum Genet; 2007 May; 80(5):876-83. PubMed ID: 17436242
[TBL] [Abstract][Full Text] [Related]
53. Molecular and cellular mechanisms of pharmacoresistance in epilepsy.
Remy S; Beck H
Brain; 2006 Jan; 129(Pt 1):18-35. PubMed ID: 16317026
[TBL] [Abstract][Full Text] [Related]
54. Genetics of drug resistance in epilepsy.
Sisodiya SM
Curr Neurol Neurosci Rep; 2005 Jul; 5(4):307-11. PubMed ID: 15987615
[TBL] [Abstract][Full Text] [Related]
55. Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin.
Tate SK; Depondt C; Sisodiya SM; Cavalleri GL; Schorge S; Soranzo N; Thom M; Sen A; Shorvon SD; Sander JW; Wood NW; Goldstein DB
Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5507-12. PubMed ID: 15805193
[TBL] [Abstract][Full Text] [Related]
56. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy.
Kwan P; Brodie MJ
Epilepsia; 2005 Feb; 46(2):224-35. PubMed ID: 15679503
[TBL] [Abstract][Full Text] [Related]
57. Listening to silence and understanding nonsense: exonic mutations that affect splicing.
Cartegni L; Chew SL; Krainer AR
Nat Rev Genet; 2002 Apr; 3(4):285-98. PubMed ID: 11967553
[TBL] [Abstract][Full Text] [Related]
58. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.
Hoffmeyer S; Burk O; von Richter O; Arnold HP; Brockmöller J; Johne A; Cascorbi I; Gerloff T; Roots I; Eichelbaum M; Brinkmann U
Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3473-8. PubMed ID: 10716719
[TBL] [Abstract][Full Text] [Related]
59. Association between Genetic Polymorphism of
Tang HX; Ho MD; Vu NP; Cao HV; Ngo VA; Nguyen VT; Nguyen TD; Nguyen TD
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674283
[No Abstract] [Full Text] [Related]
60. Association between SCN1A polymorphism and carbamazepine responsiveness in epilepsy: A meta-analysis.
Zhang X; Liu J; Ye J
Epilepsy Res; 2021 Oct; 176():106627. PubMed ID: 34218210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
